Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30.
about
The role of physical rehabilitation in stem cell transplantation patientsSleep Patterns During Hospitalization Following Hematopoietic Stem Cell TransplantationPersistent Fatigue in Hematopoietic Stem Cell Transplantation SurvivorsInterdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study.Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data.Risk factors for depression in patients undergoing hematopoietic cell transplantation.Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical managementPatient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapyLong-term follow-up after allogeneic stem cell transplantationFactors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional studyPhysical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cWhich questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?Haploidentical hematopoietic stem cell transplantation without in vitro T-cell-depletion for the treatment of hematologic diseases.Symptoms and Quality of Life: Before and after stem cell transplantation in cancerPsychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathwaysEvaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation.Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.Real-time Fatigue and Free-Living Physical Activity in Hematopoietic Stem Cell Transplantation Cancer Survivors and Healthy Controls: A Preliminary Examination of the Temporal, Dynamic Relationship.Resilience in patients after allogeneic stem cell transplantation.Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.A cross-sectional study on vision-related quality of life in patients with ocular GvHD.Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients.Social impairment of patients undergoing hematopoietic stem cell transplant.Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation.The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.Occupational status among adult survivors following allo-SCT.Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT.Systematic review of health state utility values for acute myeloid leukemia.Psychosocial supportive care services for haematopoietic stem cell transplant patients; a service evaluation of three UK transplant centres.Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United KingdomHematopoietic stem cell transplantation and quality of life during the first year of treatment
P2860
Q28087720-8D312FE6-0B2C-4840-A8C7-5749E5273D09Q28386551-7AA6E003-9EAA-4175-8261-8CE833BFD56CQ28397005-AAE5B4A3-C385-4ED3-BB24-4C815327A024Q30315577-DD9A6FC9-2B85-4CB6-A078-749C47C6E879Q31122330-E79F1A50-65AE-468B-9B4F-8349BCABA811Q33756695-368B3113-5398-4082-91F4-BD7D69FD81DEQ34175300-52773071-E12F-40AD-B39F-70F2C196657FQ34640628-27928074-2FCB-43A9-900C-873062E4E9B6Q35104794-3E509E14-5C01-4FC1-82C8-7C20EE7F610CQ35146910-DB27B14A-B19A-4DB0-A7E2-EFE688CCF518Q35765750-45856C98-12B5-4941-BD9C-C35F1BD6AF07Q36707816-31D21F2B-056F-4042-A2F7-DE578C7A293EQ36846213-BBF47C27-2962-4E74-8009-2EF7823E8D50Q37258003-A37D0A95-D620-4E8F-9D87-A6F679884EA6Q37266089-E4F8927A-EDA8-4E1D-A8BA-EE1480E65725Q37571703-628B6919-A2B3-47AC-880F-4C925387C6CDQ37624296-35DEDB94-61D3-4FF6-8806-09DA8D761962Q38808511-3ADDCF6E-2E5B-47F1-AD5F-F4996F094AA5Q38817270-5F99AE49-D9AC-4BEC-B66A-FD322552641CQ39126825-64943E5F-403B-42AF-809E-5BD0BF204923Q39304819-A3232910-F0CE-4560-973D-DDBAE61CCF36Q40038510-76C0218B-6A80-49F5-B51A-D099039DC2B3Q40948883-CD5422CA-8846-488A-A61E-EFE39531C5FBQ41614364-DEA82BFE-AD71-4FEC-9324-A2D08F7B2B03Q41687089-33EF6795-6727-4603-887C-DE6B723E5654Q41995096-DAE586CF-3467-4FBC-8124-852F93DB9257Q44453411-49DE5A23-0BFE-4021-9839-FE24A274DA3EQ47415771-B9C81A61-3C10-4D46-AB54-A9560216F375Q47575184-CD5AF7EF-2ECC-40B6-BF66-706BC72EFE51Q47911006-54B4D844-A1BF-4DAF-BFF1-7DA5913A2E1EQ47957199-B2606A71-F568-4581-A9BF-4634EF3BFE1EQ48083536-242C518F-1B2B-42CD-A3B8-55C1D4ACA39CQ48222982-C2908EF9-039C-4529-8F48-C55417FC8BA4Q48324199-5E7BD718-27F1-432F-A552-96D86B492D99Q49780236-3229321D-62F3-44EF-97A0-0782B256B660Q50672020-EBB46B82-1F69-4182-A8B9-8065A414A622Q52689260-8AF7D198-B9AB-4F43-B89D-6E2BF1488C81Q55303915-49DE722E-7978-4C18-870C-64FCFA9839B7Q57483591-312DEEB8-49C9-4459-AC13-080517A51C7FQ58117403-9D00A373-9EED-4F61-AF54-995885D0FD61
P2860
Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quality of life in patients be ...... fe Core Questionnaire QLQ-C30.
@en
Quality of life in patients be ...... search and Treatment of Cancer
@nl
type
label
Quality of life in patients be ...... fe Core Questionnaire QLQ-C30.
@en
Quality of life in patients be ...... search and Treatment of Cancer
@nl
prefLabel
Quality of life in patients be ...... fe Core Questionnaire QLQ-C30.
@en
Quality of life in patients be ...... search and Treatment of Cancer
@nl
P2093
P2860
P921
P356
P1476
Quality of life in patients be ...... fe Core Questionnaire QLQ-C30.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2011.107
P407
P577
2011-05-23T00:00:00Z